Navigation Links
A sweet step toward new cancer therapies

By recognizing sugars, a technique developed by University of Michigan analytical chemist Kristina Hakansson sets the stage for new cancer diagnosis and treatment options.

A growing body of evidence points to assemblies of sugars called glycans attached to proteins on cancer cell surfaces as accomplices in the growth and spread of tumors. Researchers have been keen to characterize these glycans, but traditional analytical methods have not been sufficient.

Now, Hakansson's research group has demonstrated that their technique can be used to identify and structurally characterize glycans. Their work is described in the April 15 issue of the journal Analytical Chemistry.

Typically, analytical chemists use mass spectrometry---a technique that accurately weighs molecules or fragments of molecules---to analyze proteins. In this process, proteins are introduced into the mass spectrometer and fragmented by heating until the weakest bonds break. "It's the 'shake-it-til-it-breaks' approach," Hakansson said.

Together, the masses of the various fragments provide a sort of fingerprint that reveals the genetic blueprint from which the protein was built---information that helps researchers confirm the protein's identity. This works fine as long as the protein has not been modified after it was produced. But if other chemical groups such as phosphates, sulfates or sugars have been added, the identification method breaks down.

"If sugars are attached, for instance, the weakest bonds are not the bonds that hold the protein together; they're the bonds between the sugars," Hakansson said. When those bonds break, the resulting fragments don't give accurate information about either the protein's identity or the exact type and position of sugars present.

To get around that problem, researchers have used a process called electron capture dissociation (ECD) instead of the usual "shake-it-til-it breaks" method to fragment proteins. But
'"/>

Source:University of Michigan


Page: 1 2

Related biology news :

1. Bad aftertaste? New sensory on/off switch may cure bane of artificial sweetener search
2. Bitter or sweet? The same taste bud can tell the difference
3. UW-Madison scientists zero in on drugs sweet spots
4. Sweet water taste paradoxically predicts sweet taste inhibitors
5. Scientists seek to unwrap the sweet mystery of the sugar coat on bacteria
6. Healing honey: The sweet evidence revealed
7. Attacking cancers sweet tooth is effective strategy against tumors
8. A sweet solution for Alzheimers disease?
9. Uncovering DNAs sweet secret
10. Unchecked DNA replication drives earliest steps toward cancer
11. Virologists make major step towards understanding the process of HIV infection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: sweet step toward new cancer therapies

(Date:11/24/2009)..., The atomic-level action of a remarkable class o... researchers with the Lawrence Berkeley National L...protein crystallography beamline at the Advanced L...al roles in gene expression and replication, and a...as well as infectious agents, such as the human pa...
(Date:11/24/2009)..., What constitutes fish food is a matter of deba... that fish get almost 50 percent of their carbon f...nk between the terrestrial and aquatic ecosystems....ngton shows this is not likely to be true. Algae p...ic life, according to research published this week...
(Date:11/23/2009)..., Washington, D.C. The community-associated stra... bacteria resistant to most common antibioticspose...n and is making its way into hospitals, according ...ctious Diseases . , The new threat is easily pi...lic places and has increased the overall burden of...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 1California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 2Mad As Hell Doctors to Hold Final 26quot 3BWhite Ribbon Rally 26quot 3B for Single Payer in Washington D C on September 30th 58388 1Mad As Hell Doctors to Hold Final 26quot 3BWhite Ribbon Rally 26quot 3B for Single Payer in Washington D C on September 30th 58388 2Mad As Hell Doctors to Hold Final 26quot 3BWhite Ribbon Rally 26quot 3B for Single Payer in Washington D C on September 30th 58388 3Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 1Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 2Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 3Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 4
...fly? The fly,s secret in avoiding death in this wa...out of the way. "This kind of low-power decision-m...omously navigating robots", according to Gwyneth C... will be presenting her work on triggered escape r...nual Main Meeting in Barcelona, on Wednesday 13th ...
...e creation of reading matter, a "nano-printing" te...duction of nano-devices currently built one at a t...vation is the DNA microarray, a nano-device used t...s Alzheimer,s, viral illnesses such as AIDS, and c...uce these complex devices would make DNA analysis ...
...dard for treating newborns suffering from opiate w...ates themselves are superior to sedatives for trea...adone while pregnant. , Opiates appear to better "...potentially reduce the likelihood of seizures," ac...d Osborn, a neonatologist at the Royal Prince Alfr...
Other Biology News:New technique may speed DNA analysis 2Opiates Better Than Sedatives For Treating Newborns In Withdrawal 2
(Date:11/25/2009)...tochromatodayannouncedtheappointmentofPeterMoldt,P...kSporkastheNovoA/SrepresentativeontheCompany,sBoar...ers. ,, "WeareverypleasedtowelcomePeterMoldttot...andguidanceasCytochromacontinuestomakeprogressinbe...mpany,"statedAlanLewis,PhD,ChairmanofCytochroma,sB...
(Date:11/25/2009)...Call/--ArdeaBiosciences,Inc.(Nasdaq: RDEA )announc...executiveofficer,willpresentatthePiperJaffray21stA...areasfollows:,PiperJaffray21stAnnualHealthCareCon...asternTime,Location:TheNewYorkPalaceHotel,NewYork,...ye/,target=,_blank,title=,http://www.corporate-ir...
(Date:11/24/2009)...also Visit Detroit , (Voc...ench Ambassador for International Investment, and ... , , ,What: Ambassador Appia is available to meet...ives adopted by France to further develop the fina...n and development., , ,When: Available for Intervi...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--DowAgroSciencesCanadaanno...isionofThompsonsLimitedofBlenheim,Ontario.Theaddit...urrentseedsbusinessasthecompanyanticipatestheintro...esHerbicideTolerantTraitTechnologyincornin2012.The... "Thisacquisitionbringstogethertwostrongprogressiv...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...e Growth Plan on Tuesday, May 20th, FREDERICK, Md...), the maker of the ActiPatch(TM), a drug free,ant...ated microchip,delivering weeks of continuous puls... it will hold a conference call to update investor...pany. Andrew Whelan, President and CEO of,BioElect...
...al, Inc., a,developer of innovative therapies in w... $49.5 million in Series D preferred stock financi...reeArch Partners and Skyline,Ventures also partici...articipation by existing investors Affinity Capita... Venture Partners, INVESCO Private Capital,JP Morg...
...n in 2008 -, FREMONT, Calif., May 15 Vermillion,...mpany, today announced financial,results for the f... update,on recent corporate and clinical developme...strated significant clinical,and commercialization...e,programs target significant unmet clinical needs...
Other Biology Technology:BioElectronics Announces Conference Call to Update Investors on Growth Initiatives 2BioElectronics Announces Conference Call to Update Investors on Growth Initiatives 3Novasys Medical Secures $49.5 Million in Series D Financing to Expand Commercialization of Its Renessa(R) Treatment for Incontinence in Women 2Vermillion Announces First Quarter 2008 Financial Results and Business Progress 2Vermillion Announces First Quarter 2008 Financial Results and Business Progress 3Vermillion Announces First Quarter 2008 Financial Results and Business Progress 4Vermillion Announces First Quarter 2008 Financial Results and Business Progress 5Vermillion Announces First Quarter 2008 Financial Results and Business Progress 6Vermillion Announces First Quarter 2008 Financial Results and Business Progress 7Vermillion Announces First Quarter 2008 Financial Results and Business Progress 8Vermillion Announces First Quarter 2008 Financial Results and Business Progress 9
Mouse Anti-TGE Virus peplomer Monoclonal Antibody, Unconjugated, Clone 1Q17 from Abcam
Anti-Jak3 Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-14-3-3 tau Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Human ThPok Polyclonal Antibody, Unconjugated from Abcam
Biology Products: